Carrier Global Corporation has completed a new investment through Carrier Ventures in Ember LifeSciences.
“Logistics failures within the biopharma industry result in roughly $35 billion worth of pharmaceutical products not reaching the people who need them,” said Jennifer Anderson, Senior Vice President, Strategy, Business Development & Chief Sustainability Officer, Carrier. “Ember LifeSciences offers highly complementary, disruptive next-generation technology and high-growth potential. Together, we can continue to advance the connected cold chain, build upon our Lynx digital platform and further strengthen Carrier’s position in this space.”
Ember LifeSciences launched in 2022 as a healthcare-focused spinoff of Ember Technologies, Inc., with a mission to save lives, improve patient outcomes, reduce waste and revolutionize the healthcare industry using its proprietary temperature control technology.
The company’s Ember Cube offering is the world’s first self-refrigerated, cloud-based shipping box. Using built-in cellular radio and GPS, the Ember Cube reports location, temperature and humidity levels to the cloud for real-time tracking. The reusable and rechargeable shipping box features a refrigeration system to help ensure the safety of temperature-sensitive biologics while in transit. The innovation provides a sustainable alternative and utilizes advanced technology, including a return-to-sender feature, to address the millions of pounds of annual packaging waste from the pharmaceutical cold chain that includes single-use shipping materials such as cardboard, Styrofoam and ice packs.
